<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="410">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05155813</url>
  </required_header>
  <id_info>
    <org_study_id>2021P002370</org_study_id>
    <nct_id>NCT05155813</nct_id>
  </id_info>
  <brief_title>Prevalence of Undiagnosed Sleep Apnea Among Patients With Atrial Fibrillation.</brief_title>
  <official_title>Prevalence of Sleep Apnea Among Patients With Atrial Fibrillation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Itamar Medical LTD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      We will screen consecutive patients presenting to the atrial fibrillation clinic for sleep&#xD;
      apnea using a FDA-approved home sleep testing device, WatchPAT to determine prevalence of&#xD;
      sleep apnea in a clinic-based sample.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will determine the prevalence of sleep apnea among consecutive patients with atrial&#xD;
      fibrillation (AF) regardless of symptoms and determine the predictive value of screening&#xD;
      tools for sleep apnea in this population. The primary outcome will be the prevalence of sleep&#xD;
      apnea among all-comers with AF. We will evaluate three secondary outcomes in the study.&#xD;
      First, we will determine the efficiency and time-to-diagnosis of sleep apnea using a FDA&#xD;
      approved home sleep testing device (i.e. WatchPAT). These analyses will be compared to&#xD;
      published studies performed using a traditional home sleep study test (which historically&#xD;
      takes approximately 8-10 weeks). There will be no collection of data from a non-intervention&#xD;
      group in our study. Second, we will calculate the predictive value of traditional clinical&#xD;
      screening tools in an AF population using the STOP-BANG questionnaire and Epworth Sleepiness&#xD;
      Scale. Third, we will identify potential risk factors for AF in patients with sleep apnea&#xD;
      using a logistic regression model.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 20, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of sleep apnea</measure>
    <time_frame>2 year study</time_frame>
    <description>Prevalence of sleep apnea among patients with atrial fibrillation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to diagnosis</measure>
    <time_frame>2 years</time_frame>
    <description>We will determine the efficiency and time-to-diagnosis of sleep apnea using a FDA approved home sleep testing device (i.e. WatchPAT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictive value of typical screening tools</measure>
    <time_frame>2 years</time_frame>
    <description>We calculate the predictive value of traditional clinical screening tools in an AF population using the STOP-BANG questionnaire and Epworth Sleepiness Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>2 years</time_frame>
    <description>We will compare quality of life in atrial fibrillation patients with and without sleep apnea.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk factors</measure>
    <time_frame>2 years</time_frame>
    <description>We will identify potential risk factors for AF in patients with sleep apnea using a logistic regression model</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Autonomic index</measure>
    <time_frame>2 years</time_frame>
    <description>Compare autonomic index in patients with AF who have sleep apnea versus those without sleep apnea</description>
  </other_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Prevalence of Sleep Apnea</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>WatchPAT</intervention_name>
    <description>FDA-approved portable home sleep testing device worn on the wrist.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are referred to the Atrial Fibrillation Center of Excellence by their primary&#xD;
        care provider or primary cardiologist will be screened by eligibility by study staff during&#xD;
        their first clinic visit (in-person or virtually).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of AF confirmed on any electrocardiographic recording&#xD;
&#xD;
          -  Age greater than or equal to 18&#xD;
&#xD;
          -  Ability to read and understand consent form, complete questionnaires, and provide&#xD;
             informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior diagnosis of sleep disordered breathing or negative testing within the past 2&#xD;
             years without significant change in weight or clinical symptoms of sleep apnea&#xD;
&#xD;
          -  History of Raynaud&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Sogol Javaheri, MD</last_name>
    <phone>617-983-7280</phone>
    <email>sjavaheri@bwh.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elliott Antman, MD</last_name>
    <email>eantman@rics.bwh.harvard.edu</email>
  </overall_contact_backup>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>December 1, 2021</study_first_submitted>
  <study_first_submitted_qc>December 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 14, 2021</study_first_posted>
  <last_update_submitted>December 1, 2021</last_update_submitted>
  <last_update_submitted_qc>December 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Sogol Javaheri</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>sleep apnea</keyword>
  <keyword>atrial fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

